# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-010405
Filing Date
2025-05-15
Accepted
2025-05-14 19:19:04
Documents
73
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | form10-q.htm iXBRL | 10-Q | 1014757
2 | EX-31.1 | ex31-1.htm | EX-31.1 | 18438
3 | EX-31.2 | ex31-2.htm | EX-31.2 | 18462
4 | EX-32.1 | ex32-1.htm | EX-32.1 | 8517
5 | EX-32.2 | ex32-2.htm | EX-32.2 | 8468
| Complete submission text file | 0001641172-25-010405.txt |  | 6486053

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | cdt-20250331.xsd | EX-101.SCH | 53903
7 | XBRL CALCULATION FILE | cdt-20250331_cal.xml | EX-101.CAL | 62165
8 | XBRL DEFINITION FILE | cdt-20250331_def.xml | EX-101.DEF | 283253
9 | XBRL LABEL FILE | cdt-20250331_lab.xml | EX-101.LAB | 462151
10 | XBRL PRESENTATION FILE | cdt-20250331_pre.xml | EX-101.PRE | 377619
75 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 895237

Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41245 | Film No.: 25947783
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)